Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Csnk1g2 | Mouse | 1,2-dimethylhydrazine | multiple interactions | EXP | | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of CSNK1G2 mRNA] | CTD | PMID:22206623 | Csnk1g2 | Mouse | 1,2-dimethylhydrazine | increases expression | EXP | | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of CSNK1G2 mRNA | CTD | PMID:22206623 | Csnk1g2 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of CSNK1G2 mRNA | CTD | PMID:21570461 | Csnk1g2 | Mouse | 4,4'-diaminodiphenylmethane | decreases expression | EXP | | 6480464 | 4 and 4'-diaminodiphenylmethane results in decreased expression of CSNK1G2 mRNA | CTD | PMID:18648102 | Csnk1g2 | Mouse | 4,4'-sulfonyldiphenol | multiple interactions | ISO | Csnk1g2 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CSNK1G2 mRNA | CTD | PMID:36041667 | Csnk1g2 | Mouse | 4-hydroxynon-2-enal | decreases expression | ISO | CSNK1G2 (Homo sapiens) | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of CSNK1G2 mRNA | CTD | PMID:12419474 | Csnk1g2 | Mouse | 5-aza-2'-deoxycytidine | increases expression | EXP | | 6480464 | Decitabine results in increased expression of CSNK1G2 mRNA | CTD | PMID:27915011 | Csnk1g2 | Mouse | Aflatoxin B2 alpha | decreases methylation | ISO | CSNK1G2 (Homo sapiens) | 6480464 | aflatoxin B2 results in decreased methylation of CSNK1G2 intron | CTD | PMID:30157460 | Csnk1g2 | Mouse | ammonium chloride | affects expression | ISO | Csnk1g2 (Rattus norvegicus) | 6480464 | Ammonium Chloride affects the expression of CSNK1G2 mRNA | CTD | PMID:16483693 | Csnk1g2 | Mouse | Aroclor 1254 | decreases expression | EXP | | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of CSNK1G2 mRNA | CTD | PMID:23650126 | Csnk1g2 | Mouse | arsane | affects methylation | ISO | CSNK1G2 (Homo sapiens) | 6480464 | Arsenic affects the methylation of CSNK1G2 gene | CTD | PMID:25304211 | Csnk1g2 | Mouse | arsenic atom | affects methylation | ISO | CSNK1G2 (Homo sapiens) | 6480464 | Arsenic affects the methylation of CSNK1G2 gene | CTD | PMID:25304211 | Csnk1g2 | Mouse | arsenite(3-) | increases expression | EXP | | 6480464 | arsenite results in increased expression of CSNK1G2 mRNA | CTD | PMID:18191166 | Csnk1g2 | Mouse | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of CSNK1G2 mRNA | CTD | PMID:22228805 | Csnk1g2 | Mouse | benzo[a]pyrene | increases methylation | ISO | CSNK1G2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of CSNK1G2 5' UTR and Benzo(a)pyrene results in increased methylation of CSNK1G2 promoter | CTD | PMID:27901495 | Csnk1g2 | Mouse | benzo[e]pyrene | decreases methylation | ISO | CSNK1G2 (Homo sapiens) | 6480464 | benzo(e)pyrene results in decreased methylation of CSNK1G2 intron | CTD | PMID:30157460 | Csnk1g2 | Mouse | bisphenol A | increases expression | ISO | Csnk1g2 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of CSNK1G2 mRNA | CTD | PMID:25181051 | Csnk1g2 | Mouse | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of CSNK1G2 mRNA | CTD | PMID:32156529 | Csnk1g2 | Mouse | bisphenol A | multiple interactions | ISO | Csnk1g2 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CSNK1G2 mRNA | CTD | PMID:36041667 | Csnk1g2 | Mouse | bisphenol A | decreases methylation | ISO | CSNK1G2 (Homo sapiens) | 6480464 | bisphenol A results in decreased methylation of CSNK1G2 gene | CTD | PMID:31601247 | Csnk1g2 | Mouse | bisphenol F | increases expression | ISO | CSNK1G2 (Homo sapiens) | 6480464 | bisphenol F results in increased expression of CSNK1G2 mRNA | CTD | PMID:38568856 | Csnk1g2 | Mouse | bisphenol F | multiple interactions | ISO | Csnk1g2 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of CSNK1G2 mRNA | CTD | PMID:36041667 | Csnk1g2 | Mouse | C60 fullerene | increases expression | ISO | Csnk1g2 (Rattus norvegicus) | 6480464 | fullerene C60 results in increased expression of CSNK1G2 mRNA | CTD | PMID:19167457 | Csnk1g2 | Mouse | cadmium dichloride | increases expression | ISO | Csnk1g2 (Rattus norvegicus) | 6480464 | Cadmium Chloride results in increased expression of CSNK1G2 mRNA | CTD | PMID:33453195 | Csnk1g2 | Mouse | carbon nanotube | decreases expression | EXP | | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | Csnk1g2 | Mouse | chlorpyrifos | decreases expression | EXP | | 6480464 | Chlorpyrifos results in decreased expression of CSNK1G2 mRNA | CTD | PMID:32715474 | Csnk1g2 | Mouse | chlorpyrifos | increases expression | EXP | | 6480464 | Chlorpyrifos results in increased expression of CSNK1G2 mRNA | CTD | PMID:37019170 | Csnk1g2 | Mouse | chrysene | increases expression | EXP | | 6480464 | chrysene results in increased expression of CSNK1G2 mRNA | CTD | PMID:26377693 | Csnk1g2 | Mouse | copper(II) chloride | increases expression | ISO | CSNK1G2 (Homo sapiens) | 6480464 | cupric chloride results in increased expression of CSNK1G2 mRNA | CTD | PMID:38568856 | Csnk1g2 | Mouse | Dibutyl phosphate | affects expression | ISO | CSNK1G2 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of CSNK1G2 mRNA | CTD | PMID:37042841 | Csnk1g2 | Mouse | dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of CSNK1G2 mRNA | CTD | PMID:21266533 | Csnk1g2 | Mouse | dibutyl phthalate | increases expression | ISO | Csnk1g2 (Rattus norvegicus) | 6480464 | Dibutyl Phthalate results in increased expression of CSNK1G2 mRNA | CTD | PMID:21266533 | Csnk1g2 | Mouse | dorsomorphin | multiple interactions | ISO | CSNK1G2 (Homo sapiens) | 6480464 | [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CSNK1G2 mRNA | CTD | PMID:27188386 | Csnk1g2 | Mouse | doxorubicin | decreases expression | ISO | CSNK1G2 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of CSNK1G2 mRNA | CTD | PMID:29803840 | Csnk1g2 | Mouse | fenthion | decreases expression | EXP | | 6480464 | Fenthion results in decreased expression of CSNK1G2 mRNA | CTD | PMID:34813904 | Csnk1g2 | Mouse | folic acid | multiple interactions | EXP | | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of CSNK1G2 mRNA] | CTD | PMID:22206623 | Csnk1g2 | Mouse | FR900359 | increases phosphorylation | ISO | CSNK1G2 (Homo sapiens) | 6480464 | FR900359 results in increased phosphorylation of CSNK1G2 protein | CTD | PMID:37730182 | Csnk1g2 | Mouse | hydrogen peroxide | decreases expression | ISO | CSNK1G2 (Homo sapiens) | 6480464 | Hydrogen Peroxide results in decreased expression of CSNK1G2 mRNA | CTD | PMID:12419474 | Csnk1g2 | Mouse | hydrogen peroxide | affects expression | ISO | CSNK1G2 (Homo sapiens) | 6480464 | Hydrogen Peroxide affects the expression of CSNK1G2 mRNA | CTD | PMID:21179406 | Csnk1g2 | Mouse | lipopolysaccharide | multiple interactions | ISO | CSNK1G2 (Homo sapiens) | 6480464 | [NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of CSNK1G2 mRNA | CTD | PMID:35877022 | Csnk1g2 | Mouse | methapyrilene | decreases methylation | ISO | CSNK1G2 (Homo sapiens) | 6480464 | Methapyrilene results in decreased methylation of CSNK1G2 intron | CTD | PMID:30157460 | Csnk1g2 | Mouse | methidathion | decreases expression | EXP | | 6480464 | methidathion results in decreased expression of CSNK1G2 mRNA | CTD | PMID:34813904 | Csnk1g2 | Mouse | methylmercury chloride | increases expression | ISO | CSNK1G2 (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of CSNK1G2 mRNA | CTD | PMID:23179753 and PMID:26272509 | Csnk1g2 | Mouse | methylmercury chloride | multiple interactions | ISO | CSNK1G2 (Homo sapiens) | 6480464 | [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CSNK1G2 mRNA | CTD | PMID:27188386 | Csnk1g2 | Mouse | methylparaben | increases expression | ISO | CSNK1G2 (Homo sapiens) | 6480464 | methylparaben results in increased expression of CSNK1G2 mRNA | CTD | PMID:38568856 | Csnk1g2 | Mouse | ozone | multiple interactions | ISO | CSNK1G2 (Homo sapiens) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of CSNK1G2 mRNA | CTD | PMID:35430440 | Csnk1g2 | Mouse | paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of CSNK1G2 mRNA | CTD | PMID:17562736 | Csnk1g2 | Mouse | paraquat | decreases expression | EXP | | 6480464 | Paraquat results in decreased expression of CSNK1G2 mRNA | CTD | PMID:21371552 | Csnk1g2 | Mouse | resveratrol | multiple interactions | ISO | CSNK1G2 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of CSNK1G2 mRNA | CTD | PMID:23557933 | Csnk1g2 | Mouse | SB 431542 | multiple interactions | ISO | CSNK1G2 (Homo sapiens) | 6480464 | [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CSNK1G2 mRNA | CTD | PMID:27188386 | Csnk1g2 | Mouse | sodium arsenite | decreases expression | ISO | CSNK1G2 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of CSNK1G2 mRNA | CTD | PMID:38568856 | Csnk1g2 | Mouse | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of CSNK1G2 mRNA | CTD | PMID:36209798 | Csnk1g2 | Mouse | sunitinib | increases expression | ISO | CSNK1G2 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of CSNK1G2 mRNA | CTD | PMID:31533062 | Csnk1g2 | Mouse | thiram | decreases expression | ISO | CSNK1G2 (Homo sapiens) | 6480464 | Thiram results in decreased expression of CSNK1G2 mRNA | CTD | PMID:38568856 | Csnk1g2 | Mouse | titanium dioxide | decreases methylation | EXP | | 6480464 | titanium dioxide results in decreased methylation of CSNK1G2 gene and titanium dioxide results in decreased methylation of CSNK1G2 promoter | CTD | PMID:35295148 | Csnk1g2 | Mouse | triphenyl phosphate | affects expression | ISO | CSNK1G2 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of CSNK1G2 mRNA | CTD | PMID:37042841 | Csnk1g2 | Mouse | valproic acid | increases methylation | ISO | CSNK1G2 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of CSNK1G2 gene | CTD | PMID:29154799 | Csnk1g2 | Mouse | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of CSNK1G2 mRNA | CTD | PMID:17963808 | Csnk1g2 | Mouse | vitamin E | decreases expression | ISO | CSNK1G2 (Homo sapiens) | 6480464 | Vitamin E results in decreased expression of CSNK1G2 mRNA | CTD | PMID:19244175 | |